UBS Group AG - T2 BIOSYSTEMS INC ownership

T2 BIOSYSTEMS INC's ticker is and the CUSIP is 89853L203. A total of 42 filers reported holding T2 BIOSYSTEMS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of T2 BIOSYSTEMS INC
ValueSharesWeighting
Q3 2023$3,153
-22.7%
14,266
-75.2%
0.00%
Q2 2023$4,080
+22566.7%
57,462
+143555.0%
0.00%
Q1 2023$18
-68.4%
400.0%0.00%
Q4 2022$57400.00%
Other shareholders
T2 BIOSYSTEMS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 749,599$344,8160.30%
CVI Holdings, LLC 549,542$252,7890.10%
Anson Funds Management LP 1,050,076$483,0340.04%
GSA CAPITAL PARTNERS LLP 86,909$400.00%
Walleye Capital LLC 390,978$179,8500.00%
Hudson Bay Capital Management LP 1,302,600$599,1960.00%
Warberg Asset Management LLC 25,955$11,9390.00%
Capital Advisors, Ltd. LLC 1,439$10.00%
UBS Group AG 40$180.00%
WealthPLAN Partners, LLC 506$2330.00%
View complete list of T2 BIOSYSTEMS INC shareholders